
    
      This is a single-dose, randomized, double-blind, placebo- and active- controlled,
      parallel-group study to evaluate the analgesic onset, efficacy, and safety profile of 440 mg
      of naproxen sodium administered as two Test NPX 220 mg tablets compared with two commercial
      products and placebo over a twelve-hour period after third-molar extractions. Subjects will
      undergo dental extraction of three or four third molars.
    
  